Bausch Health completes acquisition of DURECT

Bausch Health Companies completed its acquisition of DURECT Corporation on September 11, 2025, after a tender offer. DURECT shareholders received $1.75 per share in cash plus contingent value rights tied to net sales milestones.

“Bausch Health Companies Inc. (NYSE: BHC) has completed its acquisition of DURECT Corporation.”aibio.space

• 1 source
• aibio.spaceBausch Health completes DURECT acquisitionaibio.space news deskSep 11, 2025

Summarized from public sources; check the original articles before acting on it.